QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technology Qua...
Nxera Pharma has entered an assignment agreement with Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Pharmaceuticals Ltd (&...
Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment o...
NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technolo...
ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing ther...
President Donald J. Trump has signed an executive order initiating the withdrawal of the United States from the World Health Organization (WHO). Th...
Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned a...
Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...
PharmAla Biotech Holdings Inc. a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel deriv...
Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain ...
Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, announced its innovative drug development strategy in the rigorous and cutti...
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced its latest business achievements a...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, wil...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced multiple business updates and progress on the Company's CNS and rare disease drug candidates, which wi...
© 2025 Biopharma Boardroom. All Rights Reserved.
